AspirinPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalTiclopidineTreatment OutcomeThromboxane B2Time FactorsCyclooxygenase InhibitorsPlatelet AggregationDrug Therapy, CombinationSalicylatesProspective StudiesSymptom AssessmentPlatelet Function TestsDepressionRisk FactorsDrug Administration ScheduleFollow-Up StudiesQuestionnairesDouble-Blind MethodAdministration, OralSeverity of Illness IndexBlood PlateletsSodium SalicylateFibrinolytic AgentsHemorrhageAnticoagulantsWarfarinBehavioral SymptomsTablets, Enteric-CoatedAsthma, Aspirin-InducedPsychiatric Status Rating ScalesGastrointestinal HemorrhageRadiation DosageLethal Dose 50Retrospective StudiesIbuprofenGastrointestinal DiseasesDose-Response Relationship, DrugCyclooxygenase 1Bleeding TimeRecurrenceDrug InteractionsCohort StudiesProstaglandin-Endoperoxide SynthasesPlatelet ActivationThromboxanesPrevalenceThrombosisAcetaminophenAsthmaQuality of LifeStrokeMyocardial InfarctionDrug ResistanceThromboxane A2Cyclooxygenase 2 InhibitorsDipyridamoleAffective SymptomsRisk AssessmentCross-Sectional StudiesAnxietyIncidenceGastric MucosaRadiometryRandomized Controlled Trials as TopicPainAge FactorsDepressive DisorderDrug HypersensitivityStomach UlcerLongitudinal StudiesLipoxinsFatiguePlacebosSex FactorsCase-Control StudiesInjections, IntravenousChronic DiseaseCyclooxygenase 2IndomethacinNaproxenAcute DiseaseAnalysis of VarianceSulfinpyrazoneUnited StatesProstaglandinsStress Disorders, Post-TraumaticReye SyndromeNeoplasmsLogistic ModelsComorbidityDose-Response Relationship, RadiationClinical Trials as TopicTomography, X-Ray ComputedDinoprostoneInfusions, IntravenousHeparinDrug CombinationsDose Fractionation